Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

for
Type B Aortic Dissection
Location: Aurora CO, Colorado Springs CO, Salt Lake City UT,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT06087029

Recruiting

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

for
Hepatitis C
Location: Aurora CO, Los Angeles CA, Houston TX, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: Female

Age: 16 - 45

Code: NCT07040319

Phase1, Phase2, Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

for
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes,
Location: Aurora CO, Minneapolis MN, San Antonio TX, Atlanta GA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 12+

Code: NCT06837181

Recruiting

Care in Multiple Sclerosis (MS)

for
Multiple Sclerosis
Location: Aurora CO, Houston TX, San Francisco CA, Birmingham AL,
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT07011914

Recruiting

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

for
Type 2 Diabetes Mellitus
Location: Denver CO, Idaho Falls ID, McKinney TX, Minneapolis MN,
Sponsor: Insulet Corporation

Sex: All

Age: 18 - 70+

Code: NCT07521475

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

for
Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities,
Location: Aurora CO, Kansas City KS, Minneapolis MN, Houston TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 40+

Code: NCT07201922

Phase3, Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Denver CO, Kansas City MO, Tucson AZ, Plano TX,
Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase3, Recruiting

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

for
Pancreatic Cancer
Location: Denver CO, Dallas TX, San Diego CA, Louisville KY,
Sponsor: University of Louisville

Sex: All

Age: 18+

Code: NCT02674100

Recruiting

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

for
Metastatic Soft Tissue Sarcoma,
Location: Aurora CO, Houston TX, New York NY, Miami FL
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06797999

Phase1, Phase2, Recruiting

Rare and Atypical Diabetes Network

for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Aurora CO, St Louis MO, Houston TX, Chicago IL,
Sponsor: University of South Florida

Sex: All

Age: 0+

Code: NCT05544266

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Denver CO, Aurora CO, Cheyenne WY, Grand Junction CO,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Denver CO, Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for
Non-cystic Fibrosis Bronchiectasis
Location: Denver CO, Kansas City KS, Rochester MN, Iowa City IA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase2, Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

for
Cystic Fibrosis Lung
Location: Denver CO, Kansas City KS, Tucson AZ, Dallas TX,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT05248230

Phase2, Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

for
Cystic Fibrosis, Parenthood Status
Location: Denver CO, Kansas City KS, Dallas TX, Minneapolis MN,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06296394

Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: Denver CO, Dallas TX, Cedar Rapids IA, Tyler TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase3, Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Denver CO, Salt Lake City UT, El Paso TX,
Sponsor: Rein Therapeutics

Sex: All

Age: 40+

Code: NCT06968845

Phase2, Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Denver CO, Aurora CO, Colorado Springs CO, Phoenix AZ,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase2, Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

for
Interstitial Lung Diseases,
Location: Denver CO, Salt Lake City UT, Omaha NE, Kansas City KS,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06806592

Phase3, Recruiting

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

for
Ototoxicity, Drug-Induced
Location: Denver CO, Rochester MN, Tyler TX, San Francisco CA,
Sponsor: Kevin Winthrop

Sex: All

Age: 18 - 70+

Code: NCT05730283

Phase2, Recruiting